HEADER TRANSFERASE/TRANSFERASE INHIBITOR 21-JUN-17 5W84 TITLE CRYSTAL STRUCTURE OF IRAK-4 WITH A 4,6-DIAMINONICOTINAMIDE INHIBITOR TITLE 2 (COMPOUND NUMBER 4) COMPND MOL_ID: 1; COMPND 2 MOLECULE: INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 154-460; COMPND 5 SYNONYM: IRAK-4,RENAL CARCINOMA ANTIGEN NY-REN-64; COMPND 6 EC: 2.7.11.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: IRAK4; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS SERINE/THREONINE PROTEIN KINASE, TRANSFERASE, TRANSFERASE-TRANSFERASE KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.S.SACK REVDAT 2 25-OCT-17 5W84 1 JRNL REVDAT 1 11-OCT-17 5W84 0 JRNL AUTH R.S.BHIDE,A.KEON,C.WEIGELT,J.S.SACK,R.J.SCHMIDT,S.LIN, JRNL AUTH 2 H.Y.XIAO,S.H.SPERGEL,J.KEMPSON,W.J.PITTS,J.CARMAN,M.A.POSS JRNL TITL DISCOVERY AND STRUCTURE-BASED DESIGN OF JRNL TITL 2 4,6-DIAMINONICOTINAMIDES AS POTENT AND SELECTIVE IRAK4 JRNL TITL 3 INHIBITORS. JRNL REF BIOORG. MED. CHEM. LETT. V. 27 4908 2017 JRNL REFN ESSN 1464-3405 JRNL PMID 28947151 JRNL DOI 10.1016/J.BMCL.2017.09.029 REMARK 2 REMARK 2 RESOLUTION. 2.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.7 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.90 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 93.82 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.5 REMARK 3 NUMBER OF REFLECTIONS : 16956 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.202 REMARK 3 R VALUE (WORKING SET) : 0.200 REMARK 3 FREE R VALUE : 0.248 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.790 REMARK 3 FREE R VALUE TEST SET COUNT : 813 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 9 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.90 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 3.08 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.15 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2790 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2286 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2653 REMARK 3 BIN R VALUE (WORKING SET) : 0.2282 REMARK 3 BIN FREE R VALUE : 0.2375 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.91 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 137 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4241 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 56 REMARK 3 SOLVENT ATOMS : 27 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 83.58 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 12.66470 REMARK 3 B22 (A**2) : -34.79330 REMARK 3 B33 (A**2) : 22.12860 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.400 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : NULL REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.362 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : NULL REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : NULL REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.912 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.879 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 4380 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 5930 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 1519 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 122 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 675 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 4380 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 576 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 5187 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.13 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 2.59 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 20.93 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5W84 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 27-JUN-17. REMARK 100 THE DEPOSITION ID IS D_1000228586. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-NOV-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-BM REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 (DENZO) REMARK 200 DATA SCALING SOFTWARE : HKL-2000 (SCALEPACK) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 17010 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.900 REMARK 200 RESOLUTION RANGE LOW (A) : 93.820 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.5 REMARK 200 DATA REDUNDANCY : 6.500 REMARK 200 R MERGE (I) : 0.10200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.8000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.06 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.2 REMARK 200 DATA REDUNDANCY IN SHELL : 5.80 REMARK 200 R MERGE FOR SHELL (I) : 0.80000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.88 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.85 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NULL, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 44.09500 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 62.60000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 70.84000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 44.09500 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 62.60000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 70.84000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 44.09500 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 62.60000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 70.84000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 44.09500 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 62.60000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 70.84000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 156 REMARK 465 ALA A 157 REMARK 465 MET A 158 REMARK 465 GLY A 159 REMARK 465 VAL A 160 REMARK 465 SER A 161 REMARK 465 ASP A 162 REMARK 465 THR A 163 REMARK 465 ARG A 164 REMARK 465 ALA A 216 REMARK 465 ALA A 217 REMARK 465 MET A 218 REMARK 465 VAL A 219 REMARK 465 ASP A 220 REMARK 465 GLU A 224 REMARK 465 GLU A 225 REMARK 465 LEU A 226 REMARK 465 GLU A 337 REMARK 465 LYS A 338 REMARK 465 PHE A 339 REMARK 465 ALA A 340 REMARK 465 GLN A 341 REMARK 465 SER A 460 REMARK 465 GLY B 156 REMARK 465 ALA B 157 REMARK 465 MET B 158 REMARK 465 GLY B 159 REMARK 465 VAL B 160 REMARK 465 SER B 161 REMARK 465 ASP B 162 REMARK 465 THR B 163 REMARK 465 ARG B 164 REMARK 465 PHE B 165 REMARK 465 HIS B 166 REMARK 465 SER B 167 REMARK 465 LYS B 214 REMARK 465 LEU B 215 REMARK 465 ALA B 216 REMARK 465 ALA B 217 REMARK 465 MET B 218 REMARK 465 VAL B 219 REMARK 465 ASP B 220 REMARK 465 ILE B 221 REMARK 465 THR B 222 REMARK 465 THR B 223 REMARK 465 GLU B 224 REMARK 465 GLU B 225 REMARK 465 LEU B 226 REMARK 465 LYS B 227 REMARK 465 GLN B 228 REMARK 465 GLN B 229 REMARK 465 PHE B 230 REMARK 465 SER B 253 REMARK 465 ASP B 254 REMARK 465 GLY B 255 REMARK 465 ASP B 256 REMARK 465 ASP B 257 REMARK 465 LEU B 258 REMARK 465 GLU B 337 REMARK 465 LYS B 338 REMARK 465 PHE B 339 REMARK 465 ALA B 340 REMARK 465 GLN B 341 REMARK 465 SER B 460 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 227 CG CD CE NZ REMARK 470 GLN A 229 CG CD OE1 NE2 REMARK 470 GLN A 232 CG CD OE1 NE2 REMARK 470 LYS A 235 CG CD CE NZ REMARK 470 LYS A 440 CG CD CE NZ REMARK 470 LYS A 441 CG CD CE NZ REMARK 470 LYS A 443 CG CD CE NZ REMARK 470 SER B 186 OG REMARK 470 VAL B 187 CG1 CG2 REMARK 470 PHE B 197 CG CD1 CD2 CE1 CE2 CZ REMARK 470 VAL B 199 CG1 CG2 REMARK 470 LYS B 213 CG CD CE NZ REMARK 470 GLN B 232 CG CD OE1 NE2 REMARK 470 LYS B 235 CG CD CE NZ REMARK 470 GLU B 439 CG CD OE1 OE2 REMARK 470 LYS B 440 CG CD CE NZ REMARK 470 LYS B 443 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 166 124.32 169.35 REMARK 500 PHE A 168 -42.48 59.01 REMARK 500 SER A 169 114.57 75.96 REMARK 500 GLU A 194 -112.27 -130.08 REMARK 500 ASN A 206 70.79 50.31 REMARK 500 ASN A 207 -25.30 67.57 REMARK 500 GLN A 228 -83.48 -60.42 REMARK 500 ALA A 238 -53.38 79.89 REMARK 500 ASP A 311 47.28 -159.67 REMARK 500 ASP A 329 80.29 50.05 REMARK 500 ALA A 353 -33.46 85.12 REMARK 500 GLU A 406 -2.69 53.64 REMARK 500 LYS A 417 39.09 -83.14 REMARK 500 LYS A 441 -46.73 -29.77 REMARK 500 SER B 169 124.91 59.14 REMARK 500 TYR B 204 63.80 -156.47 REMARK 500 ASP B 311 47.27 -158.37 REMARK 500 ASP B 320 -169.20 -78.10 REMARK 500 ASP B 329 80.34 50.45 REMARK 500 GLU B 406 1.52 51.39 REMARK 500 LYS B 441 -36.59 -32.45 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 9YY A 4000 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 9YY B 4000 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5W86 RELATED DB: PDB REMARK 900 RELATED ID: 5W85 RELATED DB: PDB DBREF 5W84 A 160 460 UNP Q9NWZ3 IRAK4_HUMAN 36 336 DBREF 5W84 B 160 460 UNP Q9NWZ3 IRAK4_HUMAN 36 336 SEQADV 5W84 GLY A 156 UNP Q9NWZ3 EXPRESSION TAG SEQADV 5W84 ALA A 157 UNP Q9NWZ3 EXPRESSION TAG SEQADV 5W84 MET A 158 UNP Q9NWZ3 EXPRESSION TAG SEQADV 5W84 GLY A 159 UNP Q9NWZ3 EXPRESSION TAG SEQADV 5W84 GLY B 156 UNP Q9NWZ3 EXPRESSION TAG SEQADV 5W84 ALA B 157 UNP Q9NWZ3 EXPRESSION TAG SEQADV 5W84 MET B 158 UNP Q9NWZ3 EXPRESSION TAG SEQADV 5W84 GLY B 159 UNP Q9NWZ3 EXPRESSION TAG SEQRES 1 A 305 GLY ALA MET GLY VAL SER ASP THR ARG PHE HIS SER PHE SEQRES 2 A 305 SER PHE TYR GLU LEU LYS ASN VAL THR ASN ASN PHE ASP SEQRES 3 A 305 GLU ARG PRO ILE SER VAL GLY GLY ASN LYS MET GLY GLU SEQRES 4 A 305 GLY GLY PHE GLY VAL VAL TYR LYS GLY TYR VAL ASN ASN SEQRES 5 A 305 THR THR VAL ALA VAL LYS LYS LEU ALA ALA MET VAL ASP SEQRES 6 A 305 ILE THR THR GLU GLU LEU LYS GLN GLN PHE ASP GLN GLU SEQRES 7 A 305 ILE LYS VAL MET ALA LYS CYS GLN HIS GLU ASN LEU VAL SEQRES 8 A 305 GLU LEU LEU GLY PHE SER SER ASP GLY ASP ASP LEU CYS SEQRES 9 A 305 LEU VAL TYR VAL TYR MET PRO ASN GLY SER LEU LEU ASP SEQRES 10 A 305 ARG LEU SER CYS LEU ASP GLY THR PRO PRO LEU SER TRP SEQRES 11 A 305 HIS MET ARG CYS LYS ILE ALA GLN GLY ALA ALA ASN GLY SEQRES 12 A 305 ILE ASN PHE LEU HIS GLU ASN HIS HIS ILE HIS ARG ASP SEQRES 13 A 305 ILE LYS SER ALA ASN ILE LEU LEU ASP GLU ALA PHE THR SEQRES 14 A 305 ALA LYS ILE SER ASP PHE GLY LEU ALA ARG ALA SER GLU SEQRES 15 A 305 LYS PHE ALA GLN TPO VAL MET TPO SEP ARG ILE VAL GLY SEQRES 16 A 305 THR THR ALA TYR MET ALA PRO GLU ALA LEU ARG GLY GLU SEQRES 17 A 305 ILE THR PRO LYS SER ASP ILE TYR SER PHE GLY VAL VAL SEQRES 18 A 305 LEU LEU GLU ILE ILE THR GLY LEU PRO ALA VAL ASP GLU SEQRES 19 A 305 HIS ARG GLU PRO GLN LEU LEU LEU ASP ILE LYS GLU GLU SEQRES 20 A 305 ILE GLU ASP GLU GLU LYS THR ILE GLU ASP TYR ILE ASP SEQRES 21 A 305 LYS LYS MET ASN ASP ALA ASP SER THR SER VAL GLU ALA SEQRES 22 A 305 MET TYR SER VAL ALA SER GLN CYS LEU HIS GLU LYS LYS SEQRES 23 A 305 ASN LYS ARG PRO ASP ILE LYS LYS VAL GLN GLN LEU LEU SEQRES 24 A 305 GLN GLU MET THR ALA SER SEQRES 1 B 305 GLY ALA MET GLY VAL SER ASP THR ARG PHE HIS SER PHE SEQRES 2 B 305 SER PHE TYR GLU LEU LYS ASN VAL THR ASN ASN PHE ASP SEQRES 3 B 305 GLU ARG PRO ILE SER VAL GLY GLY ASN LYS MET GLY GLU SEQRES 4 B 305 GLY GLY PHE GLY VAL VAL TYR LYS GLY TYR VAL ASN ASN SEQRES 5 B 305 THR THR VAL ALA VAL LYS LYS LEU ALA ALA MET VAL ASP SEQRES 6 B 305 ILE THR THR GLU GLU LEU LYS GLN GLN PHE ASP GLN GLU SEQRES 7 B 305 ILE LYS VAL MET ALA LYS CYS GLN HIS GLU ASN LEU VAL SEQRES 8 B 305 GLU LEU LEU GLY PHE SER SER ASP GLY ASP ASP LEU CYS SEQRES 9 B 305 LEU VAL TYR VAL TYR MET PRO ASN GLY SER LEU LEU ASP SEQRES 10 B 305 ARG LEU SER CYS LEU ASP GLY THR PRO PRO LEU SER TRP SEQRES 11 B 305 HIS MET ARG CYS LYS ILE ALA GLN GLY ALA ALA ASN GLY SEQRES 12 B 305 ILE ASN PHE LEU HIS GLU ASN HIS HIS ILE HIS ARG ASP SEQRES 13 B 305 ILE LYS SER ALA ASN ILE LEU LEU ASP GLU ALA PHE THR SEQRES 14 B 305 ALA LYS ILE SER ASP PHE GLY LEU ALA ARG ALA SER GLU SEQRES 15 B 305 LYS PHE ALA GLN TPO VAL MET TPO SEP ARG ILE VAL GLY SEQRES 16 B 305 THR THR ALA TYR MET ALA PRO GLU ALA LEU ARG GLY GLU SEQRES 17 B 305 ILE THR PRO LYS SER ASP ILE TYR SER PHE GLY VAL VAL SEQRES 18 B 305 LEU LEU GLU ILE ILE THR GLY LEU PRO ALA VAL ASP GLU SEQRES 19 B 305 HIS ARG GLU PRO GLN LEU LEU LEU ASP ILE LYS GLU GLU SEQRES 20 B 305 ILE GLU ASP GLU GLU LYS THR ILE GLU ASP TYR ILE ASP SEQRES 21 B 305 LYS LYS MET ASN ASP ALA ASP SER THR SER VAL GLU ALA SEQRES 22 B 305 MET TYR SER VAL ALA SER GLN CYS LEU HIS GLU LYS LYS SEQRES 23 B 305 ASN LYS ARG PRO ASP ILE LYS LYS VAL GLN GLN LEU LEU SEQRES 24 B 305 GLN GLU MET THR ALA SER MODRES 5W84 TPO A 342 THR MODIFIED RESIDUE MODRES 5W84 TPO A 345 THR MODIFIED RESIDUE MODRES 5W84 SEP A 346 SER MODIFIED RESIDUE MODRES 5W84 TPO B 342 THR MODIFIED RESIDUE MODRES 5W84 TPO B 345 THR MODIFIED RESIDUE MODRES 5W84 SEP B 346 SER MODIFIED RESIDUE HET TPO A 342 11 HET TPO A 345 11 HET SEP A 346 10 HET TPO B 342 11 HET TPO B 345 11 HET SEP B 346 10 HET 9YY A4000 28 HET 9YY B4000 28 HETNAM TPO PHOSPHOTHREONINE HETNAM SEP PHOSPHOSERINE HETNAM 9YY 4-(BENZYLAMINO)-6-[(2-OXO-2,3-DIHYDRO-1H-INDOL-5-YL) HETNAM 2 9YY AMINO]PYRIDINE-3-CARBOXAMIDE HETSYN TPO PHOSPHONOTHREONINE HETSYN SEP PHOSPHONOSERINE FORMUL 1 TPO 4(C4 H10 N O6 P) FORMUL 1 SEP 2(C3 H8 N O6 P) FORMUL 3 9YY 2(C21 H19 N5 O2) FORMUL 5 HOH *27(H2 O) HELIX 1 AA1 SER A 169 THR A 177 1 9 HELIX 2 AA2 PRO A 184 GLY A 188 5 5 HELIX 3 AA3 GLN A 228 CYS A 240 1 13 HELIX 4 AA4 SER A 269 CYS A 276 1 8 HELIX 5 AA5 LEU A 277 THR A 280 5 4 HELIX 6 AA6 SER A 284 ASN A 305 1 22 HELIX 7 AA7 LYS A 313 ALA A 315 5 3 HELIX 8 AA8 THR A 365 GLY A 383 1 19 HELIX 9 AA9 LEU A 397 ASP A 405 1 9 HELIX 10 AB1 THR A 409 TYR A 413 5 5 HELIX 11 AB2 ASP A 422 LEU A 437 1 16 HELIX 12 AB3 LYS A 440 ARG A 444 5 5 HELIX 13 AB4 ASP A 446 ALA A 459 1 14 HELIX 14 AB5 SER B 169 THR B 177 1 9 HELIX 15 AB6 PRO B 184 GLY B 188 5 5 HELIX 16 AB7 GLN B 232 CYS B 240 1 9 HELIX 17 AB8 SER B 269 CYS B 276 1 8 HELIX 18 AB9 SER B 284 ASN B 305 1 22 HELIX 19 AC1 THR B 365 GLY B 383 1 19 HELIX 20 AC2 LEU B 397 ASP B 405 1 9 HELIX 21 AC3 THR B 409 TYR B 413 5 5 HELIX 22 AC4 ASP B 422 LEU B 437 1 16 HELIX 23 AC5 ASP B 446 ALA B 459 1 14 SHEET 1 AA1 5 LYS A 191 GLY A 193 0 SHEET 2 AA1 5 VAL A 199 VAL A 205 -1 O VAL A 200 N MET A 192 SHEET 3 AA1 5 THR A 208 LYS A 214 -1 O LYS A 214 N VAL A 199 SHEET 4 AA1 5 CYS A 259 VAL A 263 -1 O LEU A 260 N LYS A 213 SHEET 5 AA1 5 LEU A 248 SER A 252 -1 N LEU A 249 O VAL A 261 SHEET 1 AA2 2 HIS A 307 ILE A 308 0 SHEET 2 AA2 2 ARG A 334 ALA A 335 -1 O ARG A 334 N ILE A 308 SHEET 1 AA3 2 ILE A 317 LEU A 319 0 SHEET 2 AA3 2 ALA A 325 ILE A 327 -1 O LYS A 326 N LEU A 318 SHEET 1 AA4 2 VAL A 343 MET A 344 0 SHEET 2 AA4 2 GLU A 363 ILE A 364 -1 O ILE A 364 N VAL A 343 SHEET 1 AA5 5 LYS B 191 GLU B 194 0 SHEET 2 AA5 5 VAL B 199 TYR B 204 -1 O VAL B 200 N MET B 192 SHEET 3 AA5 5 THR B 209 LYS B 213 -1 O VAL B 212 N TYR B 201 SHEET 4 AA5 5 LEU B 260 VAL B 263 -1 O TYR B 262 N ALA B 211 SHEET 5 AA5 5 LEU B 248 GLY B 250 -1 N LEU B 249 O VAL B 261 SHEET 1 AA6 2 HIS B 307 ILE B 308 0 SHEET 2 AA6 2 ARG B 334 ALA B 335 -1 O ARG B 334 N ILE B 308 SHEET 1 AA7 2 ILE B 317 LEU B 319 0 SHEET 2 AA7 2 ALA B 325 ILE B 327 -1 O LYS B 326 N LEU B 318 LINK C TPO A 342 N VAL A 343 1555 1555 1.34 LINK C MET A 344 N TPO A 345 1555 1555 1.36 LINK C TPO A 345 N SEP A 346 1555 1555 1.35 LINK C SEP A 346 N ARG A 347 1555 1555 1.36 LINK C TPO B 342 N VAL B 343 1555 1555 1.34 LINK C MET B 344 N TPO B 345 1555 1555 1.34 LINK C TPO B 345 N SEP B 346 1555 1555 1.35 LINK C SEP B 346 N ARG B 347 1555 1555 1.36 CISPEP 1 GLU A 392 PRO A 393 0 4.00 CISPEP 2 GLU B 392 PRO B 393 0 3.40 SITE 1 AC1 12 MET A 192 GLY A 193 VAL A 200 ALA A 211 SITE 2 AC1 12 LYS A 213 TYR A 262 VAL A 263 TYR A 264 SITE 3 AC1 12 MET A 265 GLY A 268 LEU A 318 ASP A 329 SITE 1 AC2 13 MET B 192 GLY B 193 GLU B 194 VAL B 200 SITE 2 AC2 13 ALA B 211 VAL B 246 TYR B 262 VAL B 263 SITE 3 AC2 13 TYR B 264 MET B 265 GLY B 268 LEU B 318 SITE 4 AC2 13 ASP B 329 CRYST1 88.190 125.200 141.680 90.00 90.00 90.00 I 2 2 2 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011339 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007987 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007058 0.00000